Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/41546
Registro completo de metadados
Campo DCValorIdioma
dc.creatorSerafin, Marissa B.-
dc.creatorBottega, Angelita-
dc.creatorFoletto, Vitória S.-
dc.creatorRosa, Taciéli F. da-
dc.creatorHörner, Andreas-
dc.creatorHörner, Rosmari-
dc.date.accessioned2020-06-23T15:50:59Z-
dc.date.available2020-06-23T15:50:59Z-
dc.date.issued2020-06-
dc.identifier.citationSERAFIN, M. B. et al. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents, [S.l.], v. 55, n. 6, June 2020.pt_BR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0924857920301266pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/41546-
dc.description.abstractGiven the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceInternational Journal of Antimicrobial Agentspt_BR
dc.subjectCOVID-19pt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.titleDrug repositioning is an alternative for the treatment of coronavirus COVID-19pt_BR
dc.typeArtigopt_BR
Aparece nas coleções:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.